Expression and clinical significance of antinuclear antibody in hepatitis C virus infection

Journal of Clinical Gastroenterology

Volumn 33, Issue 5, 2001, Pages 402-406

  Peng, Yen Chun ^a   Hsieh, Song Chou ^b,c   Yang, Dar Yu ^a,d   Tung, Chun Fang ^a   Hu, Wei Hsiung ^a,d   Huang, Wen Nan ^a   Chen, Gran Hum ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antinuclear antibody; Hepatitis C virus; Speckled pattern

Indexed keywords

ALPHA FETOPROTEIN; ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOFLUORESCENCE; MALE; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ALPHA-FETOPROTEINS; ANTIBODIES, ANTINUCLEAR; ASPARTATE AMINOTRANSFERASES; CRYOGLOBULINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED;

EID: 0034749497     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200111000-00012     Document Type: Article

References (41)

1. Pathogenesis, diagnosis and management of hepatitis C
2. Hepatitis C
3. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
4. Hepatitis C virus and autoimmunity: Fortuitous association or reality?
5. A role for hepatitis C virus infection in type II cryoglobulinemia
6. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis
7. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection
8. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: Negative role of serum viral titer and genotype
9. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions
10. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
11. The 1982 revised criteria for the clarification of systemic lupus erythematosus
12. Natural history, clinical features, and treatment of autoimmune hepatitis
13. The validity and importance of subtypes of autoimmune hepatitis: A point of view
14. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
15. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease
16. Autoimmune chronic active hepatitis-a specific entity? The negative argument
17. Clinical significance and interpretation of antinuclear antibodies
18. Antinuclear antibodies as molecular and diagnostic probes
19. Antinuclear antibodies: Diagnostic markers and clues to the basis of systemic autoimmunity
20. Recently characterised autoantibodies and their clinical significance
21. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis
22. Antinuclear antibodies and patterns of nuclear immunofluorescence in type I autoimmune hepatitis
23. Non-organ specific autoantibodies associated with chronic C virus hepatitis
24. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile
25. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C genotypes
26. Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: Its relation to the efficacy of therapy
27. Non-organ specific autoantibodies in children with chronic hepatitis C
28. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C
29. Pathology of hepatitis C virus infection
30. Immune-mediated liver damage in chronic hepatitis C
31. Histopathology and pathobiology of hepatotrophic virus-induced liver injury
32. Histological findings in chronic hepatitis C with auto-immune feature
33. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults
34. Value of liver biopsy prior to interferon therapy for chronic viral hepatitis
35. Steatosis and bile duct damage in chronic hepatitis C: Distribution and relationships in a group of Northern Italian patients
36. The effectiveness of serum α-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma
37. Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C
38. Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective
39. Hepatitis C and cryoglobuhnemia
40. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia
41. Clinical study of cryoglobulinemia in Chinese patients with chronic hepatitis C